Search results for "Static"

showing 10 items of 1528 documents

Reduced Threshold for Inhibitory Homeostatic Responses in Migraine Motor Cortex? A tDCS/TMS Study

2014

Background and Objective Neurophysiological studies in migraine have reported conflicting findings of either cortical hyper- or hypoexcitability. In migraine with aura (MwA) patients, we recently documented an inhibitory response to suprathreshold, high-frequency repetitive transcranial magnetic stimulation (hf-rTMS) trains applied to the primary motor cortex, which is in contrast with the facilitatory response observed in the healthy subjects. The aim of the present study was to support the hypothesis that in migraine, because of a condition of basal increased cortical responsivity, inhibitory homeostatic-like mechanisms of cortical excitability could be induced by high magnitude stimulati…

AdultMaleMigraine Disordersmedicine.medical_treatmentTranscranial Direct Current Stimulationhomeostatic plasticityHomeostatic plasticitymedicineHomeostasisHumansmigrainemetaplasticityTranscranial direct-current stimulationMotor Cortexrepetitive transcranial magnetic stimulationEvoked Potentials Motormedicine.diseaseTranscranial Magnetic StimulationMigraine with auraTranscranial magnetic stimulationmedicine.anatomical_structureNeurologyMigraineBrain stimulationFemaleNeurology (clinical)medicine.symptomPrimary motor cortexPsychologyNeuroscienceMotor cortexHeadache: The Journal of Head and Face Pain
researchProduct

Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers

2019

Background The identification of appropriate biomarkers is essential to support important clinical decisions in patients with prostate cancer. The aim of our study was a systematic bioinformatical analysis of the mRNA expression of all genes available for the prostate adenocarcinoma cohort of The Cancer Genome Atlas (TCGA), regarding their potential prognostic and diagnostic role. Methods The study cohort comprises 499 patients (TCGA prostate cancer cohort). mRNA expression data were available for approx. 20,000 genes. The bioinformatical statistical pipeline addressed gene expression differences in tumor vs. benign prostate tissue (including gene set enrichment analysis, GSEA) in samples f…

AdultMaleOncologyBiochemical recurrencemedicine.medical_specialtyBiomedical ResearchMultivariate analysisBioinformaticsUrology030232 urology & nephrologyAdenocarcinomalcsh:RC870-923PrognosticCohort Studies03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicineBiomarkers TumormedicineHumansDiagnosticEpigeneticsAgedProstate cancerProportional hazards modelbusiness.industryHazard ratiomRNA expressionProstatic NeoplasmsGeneral MedicineMiddle Agedlcsh:Diseases of the genitourinary system. UrologyPrognosismedicine.diseaseGene Expression Regulation NeoplasticReproductive Medicine030220 oncology & carcinogenesisCohortBiomarker (medicine)businessBiomarkersResearch ArticleBMC Urology
researchProduct

Phase II Study of Bevacizumab in Combination with Trastuzumab and Capecitabine as First-Line Treatment for HER-2-positive Locally Recurrent or Metast…

2012

Abstract We report the first results from a phase II, open-label study designed to evaluate the efficacy and safety of bevacizumab in combination with trastuzumab and capecitabine as first-line therapy for human epidermal growth factor receptor (HER)-2-positive locally recurrent (LR) or metastatic breast cancer (MBC). Patients were aged ≥18 years with confirmed breast adenocarcinoma, measurable LR/MBC and documented HER-2-positive disease. Patients received bevacizumab (15 mg/kg on day 1) plus trastuzumab (8 mg/kg on day 1 of cycle 1, 6 mg/kg on day 1 of each subsequent cycle) plus capecitabine (1,000 mg/m2 twice daily, days 1–14) every 3 weeks until disease progression, unacceptable toxici…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyBevacizumabReceptor ErbB-2HER-2-positivePhases of clinical researchBreast NeoplasmsAntibodies Monoclonal HumanizedDeoxycytidineDisease-Free SurvivalBreast Neoplasms MaleCapecitabineAcademia-Pharma IntersectTrastuzumabInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineClinical endpointHumansNeoplasm MetastasisAdverse effectskin and connective tissue diseasesCapecitabineAgedAged 80 and overbusiness.industryFirst-lineMiddle AgedTrastuzumabmedicine.diseaseMetastatic breast cancerMetastatic breast cancerBevacizumabOncologyFluorouracilFemaleFluorouracilNeoplasm Recurrence Localbusinessmedicine.drug
researchProduct

Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a p…

2008

This is a phase II institutional exploratory trial of biweekly irinotecan and cetuximab administration regimen in metastatic colorectal cancer patients progressing to at least one previous chemotherapy line. A total of 40 patients were treated between November 2005 and November 2007 with irinotecan 180 mg m−2 and cetuximab 500 mg m−2 q2w (every 2 weeks), in every 21-day cycles, until unacceptable toxicity or progressive disease. An overall response rate of 22.5% was obtained (two complete and seven partial responses). The disease control rate was 60%. The time to progression was 3.4 months and the overall survival was 8 months. The toxicity compared very favourably to weekly cetuximab combi…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentCetuximabAntibodies Monoclonal HumanizedIrinotecanDrug Administration ScheduleInternal medicineAntineoplastic Combined Chemotherapy ProtocolsClinical StudiesmedicineHumansProspective StudiesNeoplasm MetastasisAdverse effectAgedChemotherapyCetuximabbusiness.industrymetastatic colorectal cancerbiweekly scheduleAntibodies MonoclonalMiddle Agedmedicine.diseaseSurgeryClinical trialIrinotecanRegimenOncologyCamptothecinFemaleColorectal NeoplasmsbusinessProgressive diseasemedicine.drugBritish Journal of Cancer
researchProduct

High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability.

2007

Mutation screening of the BRCA1 and BRCA2 genes in probands with familial breast/ovarian cancer has been greatly improved by the multiplex ligation-dependent probe amplification (MLPA) assay able to evidence gene rearrangements not detectable by standard screening methods. However, no criteria for selection of cases to be submitted to the MLPA test have been reported yet. We used the BRCAPro software for the selection of familial breast/ovarian cancer probands investigated with the MLPA approach after negative BRCA1/2 conventional mutation screening. One hundred and seventy-seven probands were investigated for germline BRCA1/2 mutations after assessment of genetic risk using BRCAPro. Proban…

AdultMaleOncologyProbandcongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyendocrine system diseasesBreast NeoplasmsGermlineBreast Neoplasms MaleGermline mutationBreast cancerRisk FactorsInternal medicinePrevalenceHumansMedicineGenetic Predisposition to DiseaseMultiplexMultiplex ligation-dependent probe amplificationskin and connective tissue diseasesAgedSequence DeletionOvarian NeoplasmsGeneticsBRCA1 Proteinbusiness.industryGenetic Carrier ScreeningProstatic NeoplasmsHematologyMiddle Agedmedicine.diseaseBRCA1 BRCA2 BRCAPro breast cancer MLPA ovarian cancerPedigreeOncologyMutation (genetic algorithm)FemalebusinessOvarian cancerSoftware
researchProduct

Metastatic carcinoma of the oral region: An analysis of 21 cases

2017

Background Metastatic carcinoma to the jaws and oral region are very rare, representing less than 1% of all oral tumors. Unfortunately, oral metastasis is usually manifestation of an advanced stage of primary cancer, and indicates widespread disease and poor prognosis. Material and Methods In this retrospective study, a total of 2039 patients with history of oral malignant tumor between 1980 and 2012 at Seoul National University Dental Hospital were evaluated. We analyzed the dental and medical records, and histopathological database of 2039 patients to assess the prevalence of oral metastasis of carcinoma in terms of sex and age, as well as, the most common origin of primary cancer, and pr…

AdultMaleOncologymedicine.medical_specialtyMetastatic carcinomaMetastasis03 medical and health sciences0302 clinical medicineInternal medicineBiopsymedicineCarcinomaHumansGeneral DentistryAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbusiness.industryResearchMedical recordRetrospective cohort study030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseasestomatognathic diseasesOtorhinolaryngology030220 oncology & carcinogenesisHepatocellular carcinomaUNESCO::CIENCIAS MÉDICASAdenocarcinomaFemaleMouth NeoplasmsSurgeryRadiologyOral SurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Effects of Stretching on Upper-Body Muscular Performance

2008

The purpose of this investigation was to examine the influence of upper-body static stretching and dynamic stretching on upper-body muscular performance. Eleven healthy men, who were National Collegiate Athletic Association Division I track and field athletes (age, 19.6 +/- 1.7 years; body mass, 93.7 +/- 13.8 kg; height, 183.6 +/- 4.6 cm; bench press 1 repetition maximum [1RM], 106.2 +/- 23.0 kg), participated in this study. Over 4 sessions, subjects participated in 4 different stretching protocols (i.e., no stretching, static stretching, dynamic stretching, and combined static and dynamic stretching) in a balanced randomized order followed by 4 tests: 30% of 1 RM bench throw, isometric ben…

AdultMaleOrthodonticsAMAXUpper bodyRepetition maximumPhysical Therapy Sports Therapy and RehabilitationGeneral MedicineIsometric exerciseAthletic PerformanceBench pressDynamic stretchingUpper ExtremityStatic stretchingMuscle Stretching ExercisesExercise TestHumansOrthopedics and Sports MedicineMuscle SkeletalThrowingMathematicsJournal of Strength and Conditioning Research
researchProduct

PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme

2017

Objectives: PCA3 performance as a single second line biomarker is compared to the European Randomised Study of Screening for Prostate Cancer risk calculator model 3 (ERSPC RC-3) in an opportunistic screening in prostate cancer (PCa). Material and methods: 5,199 men, aged 40-75y, underwent prostate-specific antigen (PSA) screening and digital rectal examination (DRE). Men with a normal DRE and PSA >= 3 ng/ml had a PCA3 test done. All men with PCA3 >= 35 underwent an initial biopsy (IBx) 12 cores. Men with PCA3 = 3 ng/ml and DRE is normal, IBx could be avoided in 12.5% less than if ERSPC RC-3 is used and would reduce the false negative cases by 36.2%. At a FU of 21.7 months, this dual protoco…

AdultMalePCA3medicine.medical_specialty030232 urology & nephrologyUrologyurologic and male genital diseaseslaw.inventionOpportunistic screening03 medical and health sciencesProstate cancerPSA0302 clinical medicineSecond lineRandomized controlled trialAntigens NeoplasmlawBiopsyBiomarkers TumormedicineHumansProspective StudiesEarly Detection of CancerAgedGynecologyProstate cancermedicine.diagnostic_testbusiness.industryProstatic NeoplasmsGeneral MedicineRectal examinationMiddle Agedmedicine.diseaseProstate cancer screening030220 oncology & carcinogenesisBiomarker (medicine)PCA3business
researchProduct

Tuberculoid leprosy and Type 1 lepra reaction.

2008

Summary A patient is described with tuberculoid leprosy and Type 1 (lepra) reaction from Sicily a non-endemic region, who lived previously in Manila from 2000 to 2005. The skin lesions became acutely inflamed and edematous. The plaques were painless to touch or pinprick, and there was swelling of the nerves in the fibro-osseous tunnels under the surface of the skin, including both the ulnar nerve at the elbow, and the posterior tibial nerve (medial malleolus). During the course of electro-neurographic studies, conduction velocity in the motory nerves indicated a slowing-down. The diagnosis of leprosy was confirmed by residence in an endemic area for about 5 years, by simultaneous skin lesio…

AdultMalePathologymedicine.medical_specialtyPosterior tibial nerveBiopsyPhilippinesElbowNeural ConductionTuberculoid leprosyLeprostatic AgentsClofazimineNerve conduction velocityDiagnosis DifferentialmedicineHumansUlnar nerveSicilyTravelmedicine.diagnostic_testbusiness.industryPublic Health Environmental and Occupational HealthTuberculoid leprosy Type 1 lepra reaction.medicine.diseaseLeprosy TuberculoidInfectious Diseasesmedicine.anatomical_structureSkin biopsyLeprosyDifferential diagnosisRifampinbusinessDapsone
researchProduct

Altered reflex sensitivity after repeated and prolonged passive muscle stretching.

1999

Experiments were carried out to test the effect of prolonged and repeated passive stretching (RPS) of the triceps surae muscle on reflex sensitivity. The results demonstrated a clear deterioration of muscle function immediately after RPS. Maximal voluntary contraction, average electromyographic activity of the gastrocnemius and soleus muscles, and zero crossing rate of the soleus muscle (recorded from 50% maximal voluntary contraction) decreased on average by 23.2, 19.9, 16.5, and 12.2%, respectively. These changes were associated with a clear immediate reduction in the reflex sensitivity; stretch reflex peak-to-peak amplitude decreased by 84.8%, and the ratio of the electrically induced m…

AdultMaleReflex StretchTime FactorsPhysiologyPassive stretchingElectromyographyDynamic stretchingStatic stretchingH-ReflexTriceps surae muscleIschemiaPhysiology (medical)medicineHumansPNF stretchingStretch reflexMuscle SkeletalCreatine Kinasemedicine.diagnostic_testChemistryElectromyographyAnatomymedicine.anatomical_structureAnesthesiaMuscle FatigueReflexRegression AnalysisAnkle JointMuscle ContractionJournal of applied physiology (Bethesda, Md. : 1985)
researchProduct